Pharma & Life SciencesHIBRIDO
Big Pharma's other war: the lawsuits that keep your generic off the shelf
Every time a cheaper version of a medication is delayed, there is often a lawsuit behind it. In the dataset, 3,461 patent cases name a major generic drugmaker as the defendant — Mylan sued 472 times, Teva 457 — and the companies filing are household names: Pfizer, Novartis, AstraZeneca, Merck.
